Zevra Therapeutics Inc (ZVRA)

R&D Expense Growth

2.14%

Quarterly · Period ending:

ZVRA logo

ZVRA R&D Expense Growth

Latest reported2.14%
ZVRA Quarterly R&D Growth (QoQ) (0.00% → 2.14%)
High-resolution chart · PNG

ZVRA r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
2.1403%
67.6336%
-23.6597%
-0.0291%
5.3714%
-67.1374%
-9.4198%
4.03%
-1.8105%
2.585%
-15.0606%
65.4379%
-14.119%
176.5184%
-310.0464%
-76.0219%
628.6827%
9.7188%
25.4578%
-21.3834%
25.7395%
-25.835%
78.701%
-12.5384%
-8.0903%
-13.7525%
-31.8308%
-24.7137%
-43.6994%
35.3268%
-52.7082%
27.0976%
-9.8737%
110.2059%
-12.0292%
35.3333%
13.0287%
-48.4009%
85.9809%
-14.0537%
54.2362%
-31.4249%
8.9649%
56.3584%
30.6277%
-64.1529%
81.7159%
89.6793%
65.2216%
30.7463%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.